BRIEF-Ovid Therapeutics Q2 Revenue USD 6.272 Million Vs. IBES Estimate USD 76.7 Thousand

Reuters
Aug 13
BRIEF-Ovid <a href="https://laohu8.com/S/LENZ">Therapeutics</a> <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue USD 6.272 Million Vs. IBES Estimate USD 76.7 Thousand

Aug 13 (Reuters) - Ovid Therapeutics Q2 net income USD -4.684 million.

  • Q2 operating expenses USD 11.345 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10